Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of Nimotuzumab Combined With Radiotherapy and Concurrently Cisplatin in Patients With Stage IIB-IVA Cervical Squamous Cell Carcinoma
Conditions
Interventions
Nimotuzumab
Cisplatin
+2 more
Locations
1
China
Zhujiang Hospital
Guangzhou, Guangdong, China
Start Date
March 20, 2018
Primary Completion Date
March 10, 2021
Completion Date
December 30, 2021
Last Updated
August 13, 2018
NCT00026884
NCT07213804
NCT07159659
NCT07169851
NCT07481851
NCT07191730
Lead Sponsor
Zhujiang Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions